Evaluation of folliculin detection by immunohistochemistry in Birt-Hogg-Dube associated kidney tumors
Iris E. Glykofridis, Irma van de Beek, Wim Vos, Pim C. Kortman, Paul van der Valk, Raimundo Freire, Arjan C. Houweling, Rob M.F. Wolthuis
This study evaluates four commercial anti-FLCN antibodies for immunohistochemistry in BHD-associated kidney tumors but finds none are reliably effective for routine diagnostic use.
bioRxiv · Jun 1, 2022 · PreprintGenetics